nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0466	0.287	CbGpPWpGaD
Lomefloxacin—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0249	0.0298	CcSEcCtD
Lomefloxacin—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.022	0.0262	CcSEcCtD
Lomefloxacin—Gout—Hydrochlorothiazide—nephrolithiasis	0.018	0.0215	CcSEcCtD
Lomefloxacin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0206	CcSEcCtD
Lomefloxacin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0159	0.019	CcSEcCtD
Lomefloxacin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0182	CcSEcCtD
Lomefloxacin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.015	0.0179	CcSEcCtD
Lomefloxacin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0166	CcSEcCtD
Lomefloxacin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0166	CcSEcCtD
Lomefloxacin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0163	CcSEcCtD
Lomefloxacin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0162	CcSEcCtD
Lomefloxacin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0156	CcSEcCtD
Lomefloxacin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.013	0.0155	CcSEcCtD
Lomefloxacin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.013	0.0155	CcSEcCtD
Lomefloxacin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.013	0.0155	CcSEcCtD
Lomefloxacin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0153	CcSEcCtD
Lomefloxacin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0151	CcSEcCtD
Lomefloxacin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0146	CcSEcCtD
Lomefloxacin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0141	CcSEcCtD
Lomefloxacin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0137	CcSEcCtD
Lomefloxacin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0137	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.011	0.0131	CcSEcCtD
Lomefloxacin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0126	CcSEcCtD
Lomefloxacin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0123	CcSEcCtD
Lomefloxacin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00988	0.0118	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00964	0.0115	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0114	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00934	0.0111	CcSEcCtD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00933	0.0575	CbGpPWpGaD
Lomefloxacin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00928	0.0111	CcSEcCtD
Lomefloxacin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0111	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00923	0.011	CcSEcCtD
Lomefloxacin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00923	0.011	CcSEcCtD
Lomefloxacin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00915	0.0109	CcSEcCtD
Lomefloxacin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00898	0.0107	CcSEcCtD
Lomefloxacin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00888	0.0106	CcSEcCtD
Lomefloxacin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00879	0.0105	CcSEcCtD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00868	0.0535	CbGpPWpGaD
Lomefloxacin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00861	0.0103	CcSEcCtD
Lomefloxacin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00848	0.0101	CcSEcCtD
Lomefloxacin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00845	0.0101	CcSEcCtD
Lomefloxacin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00839	0.01	CcSEcCtD
Lomefloxacin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00815	0.00973	CcSEcCtD
Lomefloxacin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00799	0.00954	CcSEcCtD
Lomefloxacin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00788	0.00941	CcSEcCtD
Lomefloxacin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00937	CcSEcCtD
Lomefloxacin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00755	0.00902	CcSEcCtD
Lomefloxacin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00866	CcSEcCtD
Lomefloxacin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00722	0.00862	CcSEcCtD
Lomefloxacin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0086	CcSEcCtD
Lomefloxacin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00853	CcSEcCtD
Lomefloxacin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00712	0.0085	CcSEcCtD
Lomefloxacin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00708	0.00845	CcSEcCtD
Lomefloxacin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00689	0.00823	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00683	0.00815	CcSEcCtD
Lomefloxacin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0068	0.00812	CcSEcCtD
Lomefloxacin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00807	CcSEcCtD
Lomefloxacin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00803	CcSEcCtD
Lomefloxacin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00664	0.00792	CcSEcCtD
Lomefloxacin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00661	0.00789	CcSEcCtD
Lomefloxacin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00788	CcSEcCtD
Lomefloxacin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00659	0.00786	CcSEcCtD
Lomefloxacin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00772	CcSEcCtD
Lomefloxacin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00642	0.00767	CcSEcCtD
Lomefloxacin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00627	0.00748	CcSEcCtD
Lomefloxacin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00627	0.00748	CcSEcCtD
Lomefloxacin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00627	0.00748	CcSEcCtD
Lomefloxacin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00624	0.00745	CcSEcCtD
Lomefloxacin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00739	CcSEcCtD
Lomefloxacin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00613	0.00731	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00612	0.0377	CbGpPWpGaD
Lomefloxacin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00606	0.00723	CcSEcCtD
Lomefloxacin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00717	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00717	CcSEcCtD
Lomefloxacin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00705	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00702	CcSEcCtD
Lomefloxacin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00586	0.007	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00693	CcSEcCtD
Lomefloxacin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00683	CcSEcCtD
Lomefloxacin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00561	0.0067	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0056	0.0345	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0056	0.0345	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00653	CcSEcCtD
Lomefloxacin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00648	CcSEcCtD
Lomefloxacin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00539	0.00644	CcSEcCtD
Lomefloxacin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00639	CcSEcCtD
Lomefloxacin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00637	CcSEcCtD
Lomefloxacin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00529	0.00631	CcSEcCtD
Lomefloxacin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00623	CcSEcCtD
Lomefloxacin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00618	CcSEcCtD
Lomefloxacin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00613	CcSEcCtD
Lomefloxacin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00591	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00586	CcSEcCtD
Lomefloxacin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00477	0.0057	CcSEcCtD
Lomefloxacin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00567	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00457	0.0282	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00528	CcSEcCtD
Lomefloxacin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00514	CcSEcCtD
Lomefloxacin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00507	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00424	0.0261	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00424	0.0261	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00491	CcSEcCtD
Lomefloxacin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00397	0.00474	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00394	0.0243	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00394	0.0243	CbGpPWpGaD
Lomefloxacin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00456	CcSEcCtD
Lomefloxacin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00452	CcSEcCtD
Lomefloxacin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00452	CcSEcCtD
Lomefloxacin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00449	CcSEcCtD
Lomefloxacin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00426	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00351	0.0217	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00349	0.0215	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00349	0.0215	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00311	0.0192	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00284	0.0175	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00284	0.0175	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00257	0.0159	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00255	0.0157	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00255	0.0157	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00227	0.014	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00216	0.0133	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00216	0.0133	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00208	0.0128	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00208	0.0128	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.002	0.0123	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.002	0.0123	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00179	0.011	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00179	0.011	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00158	0.00971	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00158	0.00971	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00151	0.00928	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00146	0.00903	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00146	0.00903	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00143	0.0088	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00131	0.00804	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00131	0.00804	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00104	0.00643	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.00034	0.00209	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000303	0.00187	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000258	0.00159	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000258	0.00159	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000183	0.00113	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000166	0.00102	CbGpPWpGaD
